×
×

Stille AB: Interim Report Q3 2024

Stille AB (publ) today presents the report for the third quarter 2024.

Revenue amounted to MSEK 127.9 (70.1) driven by strong organic growth in surgical instruments and the successful acquisition of Fehling. Total growth amounted to 82.4 percent, of which 7.4 percent was organic growth.

“Organic growth remained robust, despite high comparable figures and slightly lower demand in the surgical table business compared with the same quarter previous year.”, says Torbjörn Sköld and comments on the company’s revised financial targets “Our revised targets reflect our ambition to constantly improve, challenge ourselves and continue evolving.”.

The gross profit margin amounted to 51.8 percent (46.7) and operating profit before non-recurring items amounted to MSEK 23.4 (11.9).

”2024 has continued on a high note – our products are delivering value to our customers, which is creating favorable demand, strong growth and a healthy cash flow.”, concludes Stille’s CEO.

MSEK JUL-SEP
2024
JUL-SEP
2023
JAN-SEP
2024
JAN-SEP
2023
OCT-SEP
2023/24
JAN-DEC
2023
Net sales 127.9  70.1  410.2  217.6  487.4  294.9 
Gross profit, % 51.8  46.7  49.8  44.6  50.1  44.8 
EBITDA before
non-recurring items
30.2  15.5  99.9  45.0  117.5  62.6 
EBITDA before
non-recurring items, %
23.6  22.1  24.3  20.7  24.1  21.2 
EBITDA 30.2  15.5  79.8  41.7  97.5  59.3 
EBITDA, % 23.6  22.1  19.5  19.1  20.4  20.1 
Operating profit before
non-recurring items
23.4  11.9  79.4  34.3  93.4  48.3 
Operating profit before
non-recurring items, %
18.3  17.0  19.4  15.8  20.0  16.4 
Operating profit 23.4  11.9  59.4  31.0  73.3  45.0 
Operating profit, % 18.3  17.0  14.5  14.2  15.5  15.2 

Torshälla, October 24th, 2024.